Insmed Inc. buy JPMorgan Chase & Co.
Start price
03.10.24
/
50%
€65.00
Target price
03.10.25
€67.10
Performance (%)
107.69%
End price
04.10.25
€135.00
Summary
This prediction ended on 04.10.25 with a price of €135.00. With a performance of 107.69% the BUY prediction by JPMorgan_Chase___Co_ was a big success. JPMorgan_Chase___Co_ has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -4.167% | -4.167% | 59.722% |
| iShares Core DAX® | -3.509% | -8.747% | -0.997% |
| iShares Nasdaq 100 | -2.782% | -0.632% | 14.223% |
| iShares Nikkei 225® | -2.038% | -6.841% | 24.866% |
| iShares S&P 500 | -2.598% | -2.230% | 9.200% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $72.00 to $74.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten